Study Reinforces BRAF-MEK Inhibition Over Anti-BRAF Only in Advanced Melanoma

(MedPage Today) -- Combined BRAF-MEK inhibition for advanced BRAF-mutant melanoma led to significantly better progression-free survival (PFS) as compared with single-agent BRAF inhibition, according to a randomized trial. Patients who received...
Source: MedPage Today Hematology/Oncology - Category: Hematology Source Type: news